Tradestie Institutional Equity Comparison Engine

GNMX vs AKTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AKTX Overall Edge

AKTX Captures Institutional Edge (2โ€“0 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Akari Therapeutics plc ADR (0.01 USD) (AKTX) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, GNMX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus AKTX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, GNMX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AKTX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
GNMX N/M vs AKTX N/M Fwd P/E
Growth & Margin Winner AKTX
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner AKTX
1Y +24.7% vs +1339.7% ยท 52W Pos 51% vs 24%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
GNMX US Equity
GNMX
Institutional Equity
$32.06
-3.04% 1D
Market Cap N/A
1M Return -12.19%
1Y Return +24.73%
Forward P/E N/M
Unified AI Score
53.1 / 100 HOLD
Tech 25.0 Fund 48.0 Flow 50.0 Mom 70.0
AKTX NASDAQ
Akari Therapeutics plc ADR (0.01 USD)
Pharmaceutical Preparations
$7.18
+7.0% 1D
Market Cap $15.6M
1M Return -11.36%
1Y Return +1339.74%
Forward P/E N/M
Unified AI Score
50.1 / 100 HOLD
Tech 65.0 Fund 56.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GNMX +24.73% AKTX +1339.74% Spread: +1.36 pp (GNMX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GNMX TTM Op. Margin: N/A AKTX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GNMX vs AKTX. Trailing 12-month operating profitability (GNMX N/A vs AKTX 0.0%) and valuation multiples (GNMX N/M vs AKTX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GNMX (3) vs AKTX (5)
Institutional Metric GNMX AKTX Criterion Row Winner
Market Capitalization Scale N/A $15.6M Larger Scale AKTX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +0.0% Higher Growth AKTX
Operating Margin (TTM) Profitability N/A 0.0% Higher Margin AKTX
Net Profit Margin Profitability N/A 0.0% Higher Margin AKTX
Return on Equity (ROE) Capital Efficiency N/A -146.3% Higher ROE AKTX
52-Week Range Position Momentum 51% ($24โ€“$40) 24% ($0โ€“$29) Stronger Trend GNMX
Beta / 30D Volatility Risk Regime 1.19ฮฒ ยท 44% Vol 77.35ฮฒ ยท 143% Vol Lower Realized Risk GNMX
Unified Institutional Score Composite Signal 53.1 / 100 (HOLD) 50.1 / 100 (HOLD) Higher Composite GNMX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GNMX vs AKTX Buy Guide
GNMX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GNMX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AKTX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AKTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GNMX nor AKTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.